This review will describe the recent advances in the synthesis of C-nucleosides with inhibitory activity of inosine monophosphate dehydrogenase (IMPDH), a key enzyme in the biosynthesis of guanine nucleotides. The review will cover synthetic approaches of structural analogues showing modifications in the furanose ring as well as in the heterocyclic base. Heterocyclic sugar nucleoside analogues in which the furanose ring has been replaced by a different heterocyclic ring including aza analogues, thioanalogues as well as dioxolanyl and isoxazolidinyl analogues are also considered.
Introduction
Inosine monophosphate dehydrogenase (IMPDH) is a key enzyme in the biosynthesis of guanine nucleotides and, thus, pivotal for cell growth. In particular, it is the responsible of transforming inosine monophosphate (IMP) 1 into xanthosine monophosphate (XMP) 2, which is subsequently transformed into guanosine monophosphate (GMP) 3 by the action of GMP-synthetase (Scheme 1).
Scheme 1. Biosynthesis of guanine nucleotides
IMPDH was first suggested as a potential target for cancer chemotherapy by Weber and co-workers [1] after it was shown that the activity of IMPDH was amplified in a variety of tumors and rapidly proliferating tissues. The Biology of IMPDH including structure, mechanism and inhibition has been studied in detail [2] and several reviews have been focused on IMPDH as a drug target [3] in cancer, [4] antiviral, [5] immunosuppressive [6] and antimicrobial chemotherapy. [7] Typically, there are two classes of IMPDH inhibitors, [8] i.e. non-nucleoside inhibitors such as mycophenolic acid (MPA) 4 and nucleoside inhibitors. Among the latter are mizoribine 5 and ribavirin 6.
These nucleoside inhibitors produce IMPDH inhibition via their anabolite 5'-monophosphates. Whereas non-nucleoside inhibitors bind at the NAD site of the enzyme, the nucleoside analogues bind at the substrate site.
[9] Nuclear magnetic resonance and molecular modeling studies on 4 [10] indicated that MPA is capable of binding to the nicotinamide site of the enzyme mimicking the NAD + inverse regulation. [11] The mechanism of action of ribavirin has been studied in combination with interferon-α (IFNα).
[12] Crystal structure of IMPDH in complex with ribavirin demonstrates that 6 targets the substrate binding site. [13] Post-print of Current Trends in Medicinal Chemistry, 2014, 14, 1212-1224 3 Figure 1 . IMPDH inhibitors C-nucleosides, like tiazofurin 7 or benzamide riboside 10, also inhibit IMPDH but through a different mechanism of action to that observed for N-nucleosides 5 and 6. Tiazofurin 7 inhibits IMPDH after its previous activation through phosphorylation and adenylation to form the corresponding dinucleotide TAD, 9 an analogue of NAD (Scheme 2). Similarly, benzamide riboside 10 is converted into the active metabolite BAD 11. [14] In fact, the identification of the active site of the enzyme [15] and selectivity studies with enzymes from different species, [16] confirmed that nicotinamide adenine dinucleotide (NAD) analogues containing C-nucleosides bind at the NAD site of IMPDH and, thus, they can act as competitive inhibitors of the enzyme. [17] In this respect the action of nicotinamide mononucleotide adenylyltransferase (NMNAT) is crucial since this enzyme is the responsible of catalyzing the metabolic conversion of tiazofurin (and its analogues) into its active form tiazofurin adenine dinucleotide (TAD).
[18] Notably, pyridine C-nucleosides such as C-nicotinamide riboside are not metabolized into the adenylated derivatives and thus, they do not exhibit any inhibitory activity. [19] Post The chemical synthesis of nucleoside analogues is a subject of interest in the framework of medicinal chemistry. [22] Although several reviews have been reported elsewhere regarding the biological activity of compounds 7 and 12-23, [7] [8] 23 ] chemical synthesis is only discussed partially. [17, 24] This review provides the reader with an overview of the chemical synthesis of those C-nucleosides. In the case of tiazofurin and their pentose-containing analogues only methodologies developed during the last decade will be considered. Starting from diacetone-D-glucose, Chun and co-workers reported [44] The isodedoxy analogue of tiazofurin has been prepared from dideoxyribose 68 (Scheme 11). [47] Reaction of 68 with potassium cyanide afforded nitrile 69 which was transformed into thioamide 70 by Other sugar-analogues of tiazofurin including acyclic, [48] oxetane [49] and pyranosyl [50] derivatives have also been reported in the past but either low chemical yields were obtained in their synthesis or no significant biological activity was found.
Tiazofurin and sugar-containing analogues
A similar approach to that employed for preparing tiazofurin and analogues with structural modifications in the furanose ring can be employed in the synthesis of analogues with heteroatoms different from sulfur in the heterocyclic base. 
Heterocyclic sugar analogues
The synthesis of azatiazofurin 18 started from α-L-lyxopyranoside 93. Activation of the free hydroxyl group with trimethylsilyl triflate, displacement with sodium azide and further catalytic hydrogenation resulted in aminosugar 94. Construction of the 1,3-dioxolane ring was carried out by condensation the free diol 119 with 2-benzoyloxyacetaldehyde dimethyl acetal (Scheme 24). Two isomers were formed in this reaction and after chromatographic separation the desired cis isomer 120 was obtained in 51% yield from the diol after treatment with methanolic ammonia. The overall yield from D-glyceraldehyde was 17.9% / for 9 steps.
Enantiomeric ent-118 was also prepared from L-glyceraldehyde ent-117 in 10.8% overall yield (9 steps ). In order to introduce chirality in the process to obtain optically active derivatives, chiral hydroxylamines such as 130 was used to prepare the corresponding nitrones. However, any attempt of conducting the reaction in the presence of Lewis acids only afforded complex reaction mixtures of various compounds from which it was not possible to separate any adduct in a synthetically useful way.
On the other hand, the cycloaddition of nitrone 136, obtained as illustrated in Scheme 28, with chiral nonracemic monoprotected diol 137 afforded a 4:1 mixture of isomers from which compound 138 was separated. After deprotection, diol cleavage and amide formation, compound 128 was obtained in 5 steps and 53% overall yield from nitrone 136 (Scheme 29). 
Scheme 29. Reagents and conditions: (i) CH

